Paper37342192
Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities.
Araki S and 2 others. Front Oncol, 2023. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities. Papers, record 37342192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37342192
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References199
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21205200 | Serine-arginine protein kinases: a small protein kinase family with a large cellular presence. | FEBS J | 2011 | https://conductscience.org/library/papers/21205200 | PubMed |
| 2 | 31408619 | Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation. | Cancer Cell | 2019 | https://conductscience.org/library/papers/31408619 | PubMed |
| 3 | 21536904 | Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21536904 | PubMed |
| 4 | 24007862 | Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells. | Cancer Lett | 2014 | https://conductscience.org/library/papers/24007862 | PubMed |
| 5 | 20967262 | Expression of conjoined genes: another mechanism for gene regulation in eukaryotes. | PLoS One | 2010 | https://conductscience.org/library/papers/20967262 | PubMed |
| 6 | 28466384 | Splicing factor mutations in MDS RARS and MDS/MPN-RS-T. | Int J Hematol | 2017 | https://conductscience.org/library/papers/28466384 | PubMed |
| 7 | 29266803 | Structure-Based Design of Selective Noncovalent CDK12 Inhibitors. | ChemMedChem | 2018 | https://conductscience.org/library/papers/29266803 | PubMed |
| 8 | 29358035 | EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29358035 | PubMed |
| 9 | 26566663 | The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. | EMBO Rep | 2015 | https://conductscience.org/library/papers/26566663 | PubMed |
| 10 | 26500332 | Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion. | J Clin Pathol | 2016 | https://conductscience.org/library/papers/26500332 | PubMed |
| 11 | 23707382 | Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases. | J Mol Biol | 2013 | https://conductscience.org/library/papers/23707382 | PubMed |
| 12 | 27282251 | Upregulation of p27 cyclin-dependent kinase inhibitor and a C-terminus truncated form of p27 contributes to G1 phase arrest. | Sci Rep | 2016 | https://conductscience.org/library/papers/27282251 | PubMed |
| 13 | 31479715 | Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498. | Gene | 2019 | https://conductscience.org/library/papers/31479715 | PubMed |
| 14 | 32359191 | A conserved sequence motif bridges two protein kinases for enhanced phosphorylation and nuclear function of a splicing factor. | FEBS J | 2021 | https://conductscience.org/library/papers/32359191 | PubMed |
| 15 | 27622333 | Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27622333 | PubMed |
| 16 | 34092037 | Oncogenic dysregulation of pre-mRNA processing by protein kinases: challenges and therapeutic opportunities. | FEBS J | 2021 | https://conductscience.org/library/papers/34092037 | PubMed |
| 17 | 24498085 | A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. | PLoS One | 2014 | https://conductscience.org/library/papers/24498085 | PubMed |
| 18 | 28488700 | Alternative splicing as a regulator of development and tissue identity. | Nat Rev Mol Cell Biol | 2017 | https://conductscience.org/library/papers/28488700 | PubMed |
| 19 | 27397683 | Release of SR Proteins from CLK1 by SRPK1: A Symbiotic Kinase System for Phosphorylation Control of Pre-mRNA Splicing. | Mol Cell | 2016 | https://conductscience.org/library/papers/27397683 | PubMed |
| 20 | 25010863 | Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma. | Br J Cancer | 2014 | https://conductscience.org/library/papers/25010863 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942016 | Lipid Metabolism and Ferroptosis in Cancer: Regulatory Mechanisms, Alternative Splicing, and Therapeutic Implications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942016 | PubMed |
| 42819770 | mRNA processing in cancer immunotherapy: emerging targets, resistance mechanisms, and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42819770 | PubMed |
| 41771572 | SNRPD2-dependency Fuels an Oncogenic Alternative Splicing Repertoire Driving Disease Aggressiveness in Glioma. | Cancer Genomics Proteomics | 2026 | https://conductscience.org/library/papers/41771572 | PubMed |
| 41403742 | Serine/Arginine Protein Kinase Inhibitors Potentiate Melanoma Cell Death and Metastatic Inhibition Through Apoptotic Protein Triggering and Vimentin Dysregulation. | Adv Pharm Bull | 2025 | https://conductscience.org/library/papers/41403742 | PubMed |
| 41279615 | Discovery of small molecule probes targeting the 5' stem-loop in the yeast U4/U6 snRNA. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279615 | PubMed |
| 41112581 | Targeting RNA-binding proteins with small molecules: perspectives and challenges. | Front Chem | 2025 | https://conductscience.org/library/papers/41112581 | PubMed |
| 40300107 | Integrated Computational and Functional Screening Identifies G9a Inhibitors for SETD2-mutant Leukemia. | Genomics Proteomics Bioinformatics | 2025 | https://conductscience.org/library/papers/40300107 | PubMed |
| 40287469 | Comprehensive analysis of splicing variants in corneal endothelial cells of patients with Fuchs endothelial corneal dystrophy. | Sci Rep | 2025 | https://conductscience.org/library/papers/40287469 | PubMed |
| 40176684 | The Development of Selective Chemical Probes for Serine Arginine Protein Kinase 3. | Chem Biol Drug Des | 2025 | https://conductscience.org/library/papers/40176684 | PubMed |
| 40141064 | Zα and Zβ Localize ADAR1 to Flipons That Modulate Innate Immunity, Alternative Splicing, and Nonsynonymous RNA Editing. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141064 | PubMed |
| 40140908 | C9ORF72 poly-PR disrupts expression of ALS/FTD-implicated STMN2 through SRSF7. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/40140908 | PubMed |
| 40000711 | Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme. | Sci Rep | 2025 | https://conductscience.org/library/papers/40000711 | PubMed |
| 39770502 | Boronic Acid-Containing 3H- pyrazolo[4,3-f]quinoline Compounds as Dual CLK/ROCK Inhibitors with Anticancer Properties. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39770502 | PubMed |
| 39218979 | The roles and mechanisms of coding and noncoding RNA variations in cancer. | Exp Mol Med | 2024 | https://conductscience.org/library/papers/39218979 | PubMed |
| 38904016 | Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/38904016 | PubMed |
| 38884552 | Dysregulation of the TCF4 Isoform in Corneal Endothelial Cells of Patients With Fuchs Endothelial Corneal Dystrophy. | Invest Ophthalmol Vis Sci | 2024 | https://conductscience.org/library/papers/38884552 | PubMed |
| 38753413 | The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response. | Oncotarget | 2024 | https://conductscience.org/library/papers/38753413 | PubMed |
| 38658776 | Alternative splicing in prostate cancer progression and therapeutic resistance. | Oncogene | 2024 | https://conductscience.org/library/papers/38658776 | PubMed |
| 37568815 | Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37568815 | PubMed |
Genes93
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37342192
GET https://conductscience.org/api/papers/v1/37342192/references?page=2